Neohla Bio

Antwerpen ·KBO/BCE: BE 0801.148.536

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	12-05-2026	80 d early	2026-00111208
31-12-2024	31-07-2025	11-04-2025	111 d early	2025-00069344
31-12-2023	31-07-2024	03-04-2024	119 d early	2024-00057432

Metric	This company	Sector median	Position in the sector
Solvency	83.2%	49.8%	better than 81% of 81 sector peers
Net result	€-427k	€17k	better than 11% of 80 sector peers
Equity	€347k	€102k	better than 75% of 81 sector peers
Gross operating margin	€-55k	€49k	better than 11% of 76 sector peers
Total assets	€418k	€250k	better than 67% of 81 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€418k
Current assets	29/58	€418k
Amounts receivable within one year	40/41	€9k
Cash & bank	54/58	€357k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€418k
Equity	10/15	€347k
Contributions / capital	10/11	€1.24M
Accumulated profits (losses)	14	€-888k
Amounts payable	17/49	€70k
Amounts payable within one year	42/48	€70k
Trade debts payable within one year	44	€70k
Income statement
Gross operating margin	9900	€-55k
Operating result	9901	€-440k
Financial income	75	€0
Financial charges	65	€316
Result before taxes	9903	€-440k
Income taxes	67/77	€-13k
Net result for the period	9904	€-427k
Result to be appropriated	9905	€-427k

Summary